Faeth Therapeutics (FTH) had the highest return in February 2026 by a small-cap US stock, returning 225.2%.

ASSET	MONTH	% RETURN
Faeth Therapeutics (FTH)	February 2026	225.16%
Rackspace Technology (RXT)	February 2026	209.52%
Nektar Therapeutics (NKTR)	February 2026	84.98%
Opus Genetics (IRD)	February 2026	84.07%
Palvella Therapeutics (PVLA)	February 2026	70.31%
New Pacific Metals (NEWP)	February 2026	69.35%
REalloys (ALOY)	February 2026	68.12%
InnovAge (INNV)	February 2026	61.44%
Climb Bio (CLYM)	February 2026	60.67%
Oil States International (OIS)	February 2026	59.44%
Kosmos Energy (KOS)	February 2026	56.38%
MMTEC (MTC)	February 2026	55.07%
BUUU (BUUU)	February 2026	54.8%
Biodesix (BDSX)	February 2026	54.69%
Allogene Therapeutics (ALLO)	February 2026	53.59%
Larimar Therapeutics (LRMR)	February 2026	51.71%
Artiva Biotherapeutics, Inc Common Stock (ARTV)	February 2026	51.56%
Polestar Automotive Holding UK PLC Class A ADS (PSNY)	February 2026	51.27%
Prelude Therapeutics (PRLD)	February 2026	49.19%
Nanobiotix (NBTX)	February 2026	47.88%
Osisko Gold (OGG)	February 2026	45.57%
Mitek Systems (MITK)	February 2026	45.51%
Currenc Group Inc Ordinary Shares (CURR)	February 2026	43.15%
C4 Therapeutics (CCCC)	February 2026	42.11%
Innovative Aerosystems (IA)	February 2026	40.9%

Small-cap stocks are treated as having a market cap between $300M and $2B.